Connection

Xuping Xie to Animals

Back to Details
This is a "connection" page, showing publications Xuping Xie has written about Animals.
Xuping Xie
Connection Strength
0.252
Animals
  1. Making sense of spike D614G in SARS-CoV-2 transmission. Sci China Life Sci. 2021 07; 64(7):1062-1067.
    View in: PubMed
    Score: 0.027
  2. A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat Commun. 2020 10 15; 11(1):5214.
    View in: PubMed
    Score: 0.027
  3. An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe. 2020 05 13; 27(5):841-848.e3.
    View in: PubMed
    Score: 0.026
  4. Small Molecules and Antibodies for Zika Therapy. J Infect Dis. 2017 12 16; 216(suppl_10):S945-S950.
    View in: PubMed
    Score: 0.022
  5. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. 2021 08; 596(7870):109-113.
    View in: PubMed
    Score: 0.007
  6. Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease. Cell Host Microbe. 2021 07 14; 29(7):1151-1161.e5.
    View in: PubMed
    Score: 0.007
  7. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature. 2021 08; 596(7870):103-108.
    View in: PubMed
    Score: 0.007
  8. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants. Nature. 2021 08; 596(7871):273-275.
    View in: PubMed
    Score: 0.007
  9. Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants. Nature. 2021 07; 595(7869):718-723.
    View in: PubMed
    Score: 0.007
  10. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 04; 27(4):717-726.
    View in: PubMed
    Score: 0.007
  11. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence. Cell. 2021 04 15; 184(8):2229-2238.e13.
    View in: PubMed
    Score: 0.007
  12. A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation. Sci Rep. 2021 01 26; 11(1):2229.
    View in: PubMed
    Score: 0.007
  13. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021 03; 591(7849):293-299.
    View in: PubMed
    Score: 0.007
  14. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape. Nat Commun. 2021 01 20; 12(1):469.
    View in: PubMed
    Score: 0.007
  15. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021 04; 592(7852):116-121.
    View in: PubMed
    Score: 0.007
  16. Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain. mBio. 2020 10 20; 11(5).
    View in: PubMed
    Score: 0.007
  17. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020 10 06; 33(1):108234.
    View in: PubMed
    Score: 0.007
  18. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nat Commun. 2020 08 13; 11(1):4059.
    View in: PubMed
    Score: 0.007
  19. Fragile X mental retardation protein is a Zika virus restriction factor that is antagonized by subgenomic flaviviral RNA. Elife. 2018 12 04; 7.
    View in: PubMed
    Score: 0.006
  20. Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach. J Virol. 2018 11 01; 92(21).
    View in: PubMed
    Score: 0.006
  21. Potential Mechanisms for Enhanced Zika Epidemic and Disease. ACS Infect Dis. 2018 05 11; 4(5):656-659.
    View in: PubMed
    Score: 0.006
  22. Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants. PLoS One. 2018; 13(1):e0189262.
    View in: PubMed
    Score: 0.006
  23. Functional Analysis of Glycosylation of Zika Virus Envelope Protein. Cell Rep. 2017 Oct 31; 21(5):1180-1190.
    View in: PubMed
    Score: 0.005
  24. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat Commun. 2017 09 22; 8(1):676.
    View in: PubMed
    Score: 0.005
  25. A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients. EBioMedicine. 2017 Mar; 17:157-162.
    View in: PubMed
    Score: 0.005
  26. A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine. EBioMedicine. 2017 Mar; 17:145-156.
    View in: PubMed
    Score: 0.005
  27. A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis. EBioMedicine. 2017 Feb; 16:136-140.
    View in: PubMed
    Score: 0.005
  28. Reverse Genetics of Zika Virus. Methods Mol Biol. 2017; 1602:47-58.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.